Clinical Trials Directory

Trials / Unknown

UnknownNCT04647162

A Clinical Trial About the Safety of Surgical Treatment in Severe Primary Pontine Hemorrhage

Safety of Surgical Treatment In Severe Primary Pontine Hemorrhage Evacuation (STIPE): a Multicentric, Randomized, Controlled, Open-label Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary pontine hemorrhage (PPH) is not common but is the most catastrophic subtype of intracerebral hemorrhage, with acute mortality between 30% and 60%. For severe PPH, defined as Glasgow Coma score (GCS) \<8 and hematoma volume≥5ml, the mortality rate is as high as 80-100%. Guidelines from the American Heart Association and European Stroke Organization do not make definite specifications. More than a century after Finkelnburg first explored the brainstem for hematoma, however, plenty of researches have shown surgery can save lives and improve the prognosis for selective patients and can be an effective and safe treatment. This study is proposed to validate the safety of surgical treatment in severe primary pontine hemorrhage.

Detailed description

The study is being conducted from Jan 2022 to Nov 2024 in 20 neurosurgical units. This STIPE trial is an investigator-initiated, parallel (3:1 to surgical HE or MT), multi-centre, randomized controlled open-label trial following the Consolidated Standards of Reporting Trials (CONSORT) guidelines and will be conducted from Jan 2022 to Nov 2024 in 20 Tertiary hospitals in China. The flow chart of the clinical trial is presented in Figure 1. Neurosurgeons involved in the study are senior investigators with good clinical experience in sPPH management. Moreover, all investigators are well trained centrally according to the requirements.

Conditions

Interventions

TypeNameDescription
PROCEDUREhematoma evacuation by craniotomyThe intervention method of hematoma evacuation is under craniotomy.
PROCEDUREhematoma evacuation by stereotactic punctureThe intervention method of hematoma evacuation is under stereotactic puncture.
PROCEDUREhematoma evacuation by neuroendoscopyThe intervention method of hematoma evacuation is under neuroendoscopy.
OTHERlife supportThe treatments in medical group includes life support, nutrition support, and rehabilitation therapy。

Timeline

Start date
2022-01-01
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2020-11-30
Last updated
2023-12-08

Locations

20 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04647162. Inclusion in this directory is not an endorsement.